Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.
01 4Mission | CDMO
02 1Polfa Tarchomin
03 6Strides Pharma Science
04 2ANI Pharmaceuticals Inc
05 1Acarpia Farmaceutici
06 4Advicenne
07 3Ajanta Pharma Limited
08 2Alliance Pharmaceutical Company
09 3Ascent Innovative Medicines
10 2Bionpharma
11 1Ferrer Internacional
12 3HIBROW HLTHCARE
13 1Mars Therapeutics
14 1Recordati
15 2Rising Pharmaceuticals Inc
16 1SIGMA TAU
17 3Teva Pharmaceutical Industries
18 3Torrent Pharmaceuticals Limited
19 2UT Southwestern Medical Center
20 2Viatris
21 1Vital Pharma Nordic ApS
22 1West-Coast Pharmaceuticals
23 1Xgx Pharma Aps
24 3Zydus Pharmaceuticals
01 1Capsule
02 2Extended Release Granule
03 1Extended Release Tablet
04 4Extended-Release Tablet
05 2FOR SOLUTION;ORAL
06 3Granules
07 1Modified Release Tablet
08 2Oral Solution
09 2SUS
10 1TABLET (EXTENDED-RELEASE)
11 27TABLET, EXTENDED RELEASE;ORAL
12 5Tablet
13 1Tablet with modified release
14 1Blank
01 1Allowed
02 4Approved
03 3Authorized
04 1Cancelled
05 5DISCN
06 1Dossier Available
07 2Generic
08 1Prescription
09 24RX
10 11Blank
01 1Acalka
02 2Alkacite
03 1Biochetasi
04 2Gencit Simplex
05 1Kajos
06 26POTASSIUM CITRATE
07 1Potassion
08 3Potassium Citrate
09 4Sibnayal
10 1UROCIT
11 4UROCIT-K
12 1Uralyt-Urat, Granules For Oral Solution
13 6Blank
01 1Canada
02 8India
03 2Italy
04 1Norway
05 1Poland
06 2South Africa
07 4Spain
08 4Sweden
09 1Switzerland
10 29USA
Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.
Regulatory Info : RX
Registration Country : USA
Brand Name : UROCIT-K
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 5MEQ
Packaging :
Approval Date : 1985-08-30
Application Number : 19071
Regulatory Info : RX
Registration Country : USA
Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.
Regulatory Info : Dossier Available
Registration Country : Poland
Brand Name :
Dosage Form : Tablet
Dosage Strength : 1080MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Dossier Available
Registration Country : Poland
Synergice, a Strides Pharma initiative, is a new gen B2B platform for diverse portofolio needs.
Regulatory Info : RX
Registration Country : USA
Brand Name : POTASSIUM CITRATE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 5MEQ
Packaging :
Approval Date : 2017-09-11
Application Number : 206813
Regulatory Info : RX
Registration Country : USA
Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.
Regulatory Info : RX
Registration Country : USA
Brand Name : UROCIT-K
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 10MEQ
Packaging :
Approval Date : 1992-08-31
Application Number : 19071
Regulatory Info : RX
Registration Country : USA
Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.
Regulatory Info : RX
Registration Country : USA
Brand Name : UROCIT-K
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 15MEQ
Packaging :
Approval Date : 2009-12-30
Application Number : 19071
Regulatory Info : RX
Registration Country : USA
Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.
Regulatory Info : Prescription
Registration Country : Canada
Brand Name : UROCIT-K
Dosage Form : TABLET (EXTENDED-RELEASE)
Dosage Strength : 1080MG
Packaging : 100
Approval Date :
Application Number : 2353997
Regulatory Info : Prescription
Registration Country : Canada
Synergice, a Strides Pharma initiative, is a new gen B2B platform for diverse portofolio needs.
Regulatory Info : RX
Registration Country : USA
Brand Name : POTASSIUM CITRATE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 10MEQ
Packaging :
Approval Date : 2017-09-11
Application Number : 206813
Regulatory Info : RX
Registration Country : USA
Synergice, a Strides Pharma initiative, is a new gen B2B platform for diverse portofolio needs.
Regulatory Info : RX
Registration Country : USA
Brand Name : POTASSIUM CITRATE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 15MEQ
Packaging :
Approval Date : 2017-09-11
Application Number : 206813
Regulatory Info : RX
Registration Country : USA
Synergice, a Strides Pharma initiative, is a new gen B2B platform for diverse portofolio needs.
Regulatory Info :
Registration Country : India
Brand Name : Potassium Citrate
Dosage Form : Extended-Release Tablet
Dosage Strength : 5MEQ
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Synergice, a Strides Pharma initiative, is a new gen B2B platform for diverse portofolio needs.
Regulatory Info :
Registration Country : India
Brand Name : Potassium Citrate
Dosage Form : Extended-Release Tablet
Dosage Strength : 10MEQ
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Synergice, a Strides Pharma initiative, is a new gen B2B platform for diverse portofolio needs.
Regulatory Info :
Registration Country : India
Brand Name : Potassium Citrate
Dosage Form : Extended-Release Tablet
Dosage Strength : 15MEQ
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Regulatory Info : RX
Registration Country : USA
Brand Name : POTASSIUM CITRATE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 5MEQ
Packaging :
Approval Date : 2006-06-09
Application Number : 77440
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : POTASSIUM CITRATE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 10MEQ
Packaging :
Approval Date : 2006-06-09
Application Number : 77440
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : POTASSIUM CITRATE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 5MEQ
Packaging :
Approval Date : 2018-03-05
Application Number : 209758
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : POTASSIUM CITRATE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 10MEQ
Packaging :
Approval Date : 2018-03-05
Application Number : 209758
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : POTASSIUM CITRATE
Dosage Form : FOR SOLUTION;ORAL
Dosage Strength : 20MEQ/PACKET **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 1988-10-13
Application Number : 19647
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : POTASSIUM CITRATE
Dosage Form : FOR SOLUTION;ORAL
Dosage Strength : 10MEQ/PACKET **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 1988-10-13
Application Number : 19647
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : POTASSIUM CITRATE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 5MEQ
Packaging :
Approval Date : 2014-08-06
Application Number : 203546
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : POTASSIUM CITRATE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 10MEQ
Packaging :
Approval Date : 2014-08-06
Application Number : 203546
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : POTASSIUM CITRATE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 15MEQ
Packaging :
Approval Date : 2014-08-06
Application Number : 203546
Regulatory Info : RX
Registration Country : USA
